Thursday, July 19, 2018
 
 
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Direct Fed Microbial (DFM) Market Analysis 2018, Size, Share, Trend, Leading Players Updates, Future Growth, Business Prospects and In-depth Analysis Research Report by Foresight to 2023

(April 16, 2018)


""Direct Fed Microbial (DFM) Market Analysis 2018""
Global Direct Fed Microbial (DFM) Market Research Report: by Type (Bacteria, Yeast and others), by Form (Dry, Liquid and others), Livestock (Cattle, Poultry, Swine/ Pork and others) and Region - Forecast till 2023

Market Overview:

Direct fed microbial (DFM) is a live microbial feed supplement which improves the intestinal microbial balance of the host livestock. The term direct fed microbial is also referred as probiotics. The most commonly used DFM includes yeast, lactic acid bacteria, bacillus, and other bacteria. These bacteria colonize the intestine of an animal in its initial days of life. During normal fermentation, beneficial bacteria produce organic acids such as lactic acid, acetic acid, or butyric acid, which lowers the intestinal pH and prevents growth of potential pathogens. DFM are available in dry and liquid form to feed various livestock population including ruminants, poultry, swine/ pork, aquatic animals, and others.

The growth of Direct fed microbial (DFM) market was mostly triggered as it replaced antibiotics for improved health and performance of livestock. Growing demand for processed animal feed and changes in farming practices and technology are some of the factors influencing the growth of DFM market.

Increasing demand for meat and milk production is influencing the growth of animal health which has led to an increase in demand for direct fed microbial. Increasing awareness of animal nutrition and rising concern for animal health is boosting the growth of DFM market. Moreover, regional governments are forming regulations to standardize meat products to prevent consumers from the outbreak of livestock diseases which is driving the growth of DFM market.† All these factors are projected to contribute to the estimated CAGR of 6.9% of DFM market during the forecast period 2017-2023.

Receive a Sample Report @ https://www.marketresearchfuture.com/sample_request/5049

Competitive Analysis:

The major players in the Direct fed microbial (DFM) market

  • Archer Daniels Midland Company (U.S.)
  • DuPont (U.S.), Novozymes (Denmark)
  • Lallemand Inc. (Canada)
  • Novus International, Inc. (U.S.)
  • Hansen A/S (Denmark)
  • Bayer AG (Germany) and
  • Koninklijke DSM N.V. (The Netherlands)

Downstream Analysis:

Based on the type, Direct fed microbial (DFM) market is segmented into bacteria, yeast, and others. Among them, the bacteria segment is dominating the market. Moreover, the lactic acid bacteria segment is expected to be the fastest growing owing to its high effectiveness and convenience of usage.

On the basis of form, Direct fed microbial (DFM) market is segmented into dry, liquid and others. Among all, the dry form of microbial is anticipated to grow over the forecast period owing to its long shelf life and many advantages in animal feed.

Based on the livestock, Direct fed microbial (DFM) market is segmented into cattle, poultry, swine/ pork, and others. Among all, the poultry segment is dominating the market followed by the cattle segment. Increasing demand for poultry meat due to their nutritive value is driving the demand for direct fed microbial market in this segment.

Access Report Details @ https://www.marketresearchfuture.com/reports/direct-fed-microbial-market-5049

Regional Analysis:

The global Direct fed microbial (DFM) market is segmented into North America, Europe, Asia Pacific and rest of the world (RoW). North America is dominating the market followed by Europe. Owing to recent occurrences of diseases such as avian influenza and foot & mouth disease, the meat market in North America, particularly in the U.S., has become cautious about food safety and quality which is driving the growth of direct fed microbial market. Rising demand for poultry and swine products in Europe is expected to boost the direct fed microbial market in this region.

Asia Pacific is the fastest growing market in direct fed microbial. China is the major contributor of meat industry which in turn drives the direct fed microbial market in this region. Moreover, rising population followed by increasing consumption of livestock in developing countries of Asia Pacific is boosting the DFM market. Brazil and the Middle-East regions are witnessing growth in DFM market owing to increase in demand of protein intake from meat.

Media Contact

Company Name: Market Research FutureContact Person: Akash Anand


Email: [email protected]
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/direct-fed-microbial-market-5049



Source: www.abnewswire.com


Page: 1


Related Keywords:Agriculture & Farming,Business,Food & Beverage,Health & Medicine,Pharmaceuticals & Biotech,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research
  • Wireless Health Market To Witness Enhanced Growth Owing To Rising Application of Wireless Health Devices And Growing Patient-Centric Methodology Till 2025 | Million Insights

    Cancer
  • Mesothelioma is a Deadly Cancer and itís Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines